Intellia Therapeutics, Inc. (NTLA)
NASDAQ·Healthcare·Biotechnology
$12.31
-0.28%
Mkt Cap $1.37B
Analyst Ratings
Buy
11
Hold
4
Sell
1
Price Target (50 analysts)
$20.88
Range $8.00 – $35.00
Implied Upside
+69.7%
Consensus $20.88 vs current $12.31
NASDAQ·Healthcare·Biotechnology
$12.31
-0.28%
Mkt Cap $1.37B
Buy
11
Hold
4
Sell
1
Price Target (50 analysts)
$20.88
Range $8.00 – $35.00
+69.7%
Consensus $20.88 vs current $12.31